What challenges exist in ensuring equitable access to biotech treatments?

[killamch89]

As breakthroughs in biotechnology lead to revolutionary therapies, hurdles remain in making these treatments available to all. What obstacles do you see in terms of cost, distribution, regulatory approval, or infrastructure? Have you encountered examples where promising treatments were limited by socioeconomic factors or geographic disparities?